Anastas Gegov

TapImmune Inc. (OTCMKTS:TPIV) Shows Hesitation Once Again

by Anastas Gegov May 26, 2015

Although we saw many red session in the chart of TapImmune Inc. (OTCMKTS:TPIV, TPIV message board) since the beginning of the year the overall trend seems to be upward. After surging in mid-February we saw the ticker hover around the 20 cent per share mark for the next 2 months.

 

That was before TPIV took on a serious upward path in the beginning of this month, gaining around 100% in value. There was, however, some hesitation around the 30 cent per share mark. This might be due to the fact that despite TPIV’s decent cash reserves the company still fails to generate revenues.

 

Here are just some of the numbers of prime interest contained in TPIV’s financial report for the first quarter of the year.

 

  • cash: $1.45 million
  • current assets: $1.53 million
  • current liabilities: $3.3 million
  • quarterly revenues: $0
  • quarterly net loss: $981 thousand

 

Despite the controversial results from Q1 of this year we saw TPIV surge once again. The press releases coming from company HQ were enough to provide with a 25% gain on a $1.02 million daily dollar volume last Wednesday, but this is when we saw TPIV begin to hesitate once again.

 

After reaching $0.41 per share the ticker lost 7.32% in Thursday. Still, TPIV managed to finish the week in the green after a 3.95% gain in Friday’s session. As the company stock was going for a close of the week at $0.395 we saw a total of 1.35 million shares change their owners, generating $529 thousand in daily dollar volume.

 

Today we see TPIV hesitating below the 40 cent per share mark once again. Considering the lack of news coming from the company, doing your due diligence and weighing out the risks before making a play is absolutely crucial.

Comments 0

Type the characters that you see in the box (5 characters).